GlaxoSmithKline Fair Value
GL
The fair market value of GLAXO.NS stock is 1585.81 INR. Relative to the market price of 2561.15 INR GlaxoSmithKline is overvalued by 38.1%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
GlaxoSmithKline Valuation
Current GLAXO.NS share ticker price is 2561.15 INR.
The fair value level of 1585.81 INR can be considered as an effective entry point for long-term investors to start investing in GLAXO.NS stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 38% higher its fair value
Current price is 79% higher its minimum value
Current price is 102% lower its maximum value
Market price:
GLAXO.NS stock is overvalued
It means the current price may concern as a Risky Entry Point
GlaxoSmithKline Pharmaceuticals Ltd Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
148.35
2
Median P/E over 5 years
45.52
3
Minimum P/E over 5 years
15.5
4
Earning per share (last 12 months)
34.83 INR
Maximum value
1
x
4
=
5 167.68 INR
Fair value
2
x
4
=
1 585.81 INR
Minimum value
3
x
4
=
540.06 INR
GlaxoSmithKline Pharmaceuticals Ltd price metrics
10.57
Annual return (geometric mean)
28.12
Risk (standard deviation) of returns
β
0.35
Beta (volatility compared to market)